AYA-PACT: mHealth Physical Activity Intervention for Young Cancer Survivors

Sponsor
AHS Cancer Control Alberta (Other)
Overall Status
Recruiting
CT.gov ID
NCT04765241
Collaborator
University of Calgary (Other)
320
1
2
59.1
5.4

Study Details

Study Description

Brief Summary

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity
N/A

Detailed Description

Background:

There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.

Aim:

Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.

Methods:

The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
320 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The study team, with the exception of the study coordinator, will be blinded to reduce bias.
Primary Purpose:
Supportive Care
Official Title:
Adolescents and Young Adults Becoming Physically Active After Cancer Trial
Actual Study Start Date :
Sep 27, 2021
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: mHealth Physical Activity Intervention

The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline

Behavioral: Physical Activity
The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff.

No Intervention: Control

Controls will receive general health education materials

Outcome Measures

Primary Outcome Measures

  1. Changes in weekly minutes of moderate-vigorous intensity physical activity [Baseline, 6 months, 12 months, 24 months]

    Measured by Actigraph

Secondary Outcome Measures

  1. Changes in weekly minutes of sedentary time [Baseline, 6 months,12 months]

    Measured by Actigraph

  2. Changes in weekly minutes of sleep [Baseline, 6 months,12 months]

    Measured by Actigraph

  3. Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score [Baseline, 6 months,12 months]

    Global score range is 0 to 23 where higher scores indicate worse sleep quality

  4. Changes in weight [Baseline, 6 months,12 months]

    Measured in kilograms

  5. Changes in body mass index (BMI) [Baseline, 6 months,12 months]

    Measured by combining height (meters) and weight (kilograms) and reported in kg/m2

  6. Changes in waist and hip circumference [Baseline, 6 months,12 months]

    Measured in centimeters

  7. Changes in cardiorespiratory fitness [Baseline, 6 months,12 months]

    Measured by peak oxygen consumption in relative (ml/kg/min) values using the incremental Balke and Ware treadmill test with direct measures of gas exchange and ventilation

  8. Changes in cardiorespiratory fitness [Baseline, 6 months,12 months]

    Measured by peak oxygen consumption in absolute (L/min) values using the incremental Balke and Ware treadmill test with direct measures of gas exchange and ventilation

  9. Changes in grip strength [Baseline, 6 months,12 months]

    Measured in kilograms using a hand dynamometer

  10. Changes in upper body muscular strength [Baseline, 6 months,12 months]

    Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM

  11. Changes in upper body muscular endurance [Baseline, 6 months,12 months]

    Measured in kilograms using the maximum number of chest press repetitions completed at 50-70% of estimated 1-RM

  12. Changes in lower body muscular strength [Baseline, 6 months,12 months]

    Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM

  13. Changes in lower body muscular endurance [Baseline, 6 months,12 months]

    Measured in kilograms using the maximum number of leg press repetitions completed at 50-70% of estimated 1-RM

  14. Changes in frailty [Baseline, 6 months,12 months]

    Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness

  15. Changes in the Short Form 36 (SF-36) Mental Health Component subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate better mental health

  16. Changes in the Short Form 36 (SF-36) Physical Health Component subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate better physical health

  17. Changes in the Short Form 36 (SF-36) Physical Functioning subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate higher functioning

  18. Changes in the Short Form 36 (SF-36) Role-physical subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate higher functioning

  19. Changes in the Short Form 36 (SF-36) Bodily Pain subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate less pain

  20. Changes in the Short Form 36 (SF-36) General Health subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate better health

  21. Changes in the Short Form 36 (SF-36) Vitality subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate higher vitality

  22. Changes in the Short Form 36 (SF-36) Social Functioning subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate higher functioning

  23. Changes in the Short Form 36 (SF-36) Role-emotional subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate higher functioning

  24. Changes in the Short Form 36 Mental Health subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 100 where higher scores indicate better mental health

  25. Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  26. Changes in the Cancer Distress Scales for AYAs Physical subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  27. Changes in the Cancer Distress Scales for AYAs Emotional subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  28. Changes in the Cancer Distress Scales for AYAs Cognitive subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  29. Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  30. Changes in the Cancer Distress Scales for AYAs Employment subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  31. Changes in the Cancer Distress Scales for AYAs Education subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  32. Changes in the Cancer Distress Scales for AYAs Practical subscale [Baseline, 6 months,12 months]

    Scores range from 0 to 100 where higher scores indicate more distress

  33. Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 80. Higher scores indicate poorer quality of life.

  34. Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 16 where higher scores indicate poorer cognition

  35. Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 36 where higher scores indicate poorer cognition

  36. Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale [Baseline, 6 months,12 months]

    Score range is from 0 to 16 where higher scores indicate poorer cognition

  37. Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F) [Baseline, 6 months,12 months]

    Score range is from 0 to 52 where higher scores indicate less fatigue

  38. Changes in the Comprehensive Score for Financial Toxicity (COST) [Baseline, 6 months,12 months]

    Score range is from 0 to 44 where higher scores indicate better financial wellbeing

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 39 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Lives in Alberta

  • Diagnosed with invasive malignancy in Alberta

  • Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences

  • Have the ability to read, write and speak English

  • Have access to the Internet on at least a weekly basis

  • Have a mobile phone with a text messaging plan

  • Willing to be randomized to either arm.

Exclusion Criteria:
  • Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)

  • Currently pregnant or planning to become pregnant within the next 6 months

  • Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Holy Cross Centre Calgary Alberta Canada T2S 3C3

Sponsors and Collaborators

  • AHS Cancer Control Alberta
  • University of Calgary

Investigators

  • Study Director: Christine Friedenreich, Alberta Health services
  • Principal Investigator: Miranda Fidler-Benaoudia, Alberta Health services

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT04765241
Other Study ID Numbers:
  • HREBA.CC-20-0397
First Posted:
Feb 21, 2021
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by AHS Cancer Control Alberta

Study Results

No Results Posted as of Oct 14, 2021